Back to Peptide Pedia
Metabolic & Weight
Emerging Research

Adipotide

ADIPO

Pro-apoptotic peptide studied in adipose research.

Also known as: Prohibitin-TP01, FTPP

Research dose rangeInvestigational (preclinical models)
Route studiedSubcutaneous (research)
Study durationShort experimental courses
Storage2–8 °C reconstituted

Overview

Adipotide is a peptidomimetic studied in adipose-tissue research for its targeting of the blood supply to fat tissue in preclinical models.

Key research findings

An experimental pro-apoptotic peptide that targets prohibitin on the vasculature feeding white adipose tissue, studied in animal models for rapid fat-mass reduction by cutting the blood supply to fat cells. A genuinely investigational compound — most data are preclinical (including primate studies).

Mechanism of action

Targets prohibitin on adipose-vasculature endothelium, studied for triggering apoptosis of fat-tissue blood supply.

Molecular information

Weight~2,621 Da
LengthPeptidomimetic conjugate
TypeProhibitin-targeting pro-apoptotic peptide
Amino-acid sequenceCKGGRAKDC cyclic homing peptide fused to a D(KLAKLAK)₂ pro-apoptotic domain.

Also called Prohibitin-TP01; the homing motif directs the apoptotic domain to adipose vasculature.

Pharmacokinetics

Peak: ~1 hourHalf-life: Short (~hours)Cleared: ~24 hours
Peak · 2hHalf-life · 7h

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

  • Adipose-vasculature research
  • Body-composition studies
  • Targeted-apoptosis investigations

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

  1. Preclinical courses

    Animal studies report rapid fat-mass reduction over short experimental treatment windows.

  2. Post-treatment

    Weight regain reported after cessation in some models.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

AOD-9604

Both target adipose by different mechanisms; no human combination data.

Use caution

Tesofensine

Distinct mechanisms; investigational status warrants caution.

Use caution

How to reconstitute

Important

Reconstitute with bacteriostatic water, swirl gently, and refrigerate. This is a highly investigational compound with very limited safety characterization.

  1. 1Allow the vial to reach room temperature.
  2. 2Swab the stopper with alcohol and let it air dry.
  3. 3Add bacteriostatic water slowly down the vial wall.
  4. 4Swirl gently until dissolved — do not shake.
  5. 5Refrigerate at 2–8 °C and protect from light.
Open reconstitution calculator

Quality indicators

White, uniform cake

Lyophilized powder should be a white to off-white cake with no discoloration, filling the base of the vial.

Clear solution after reconstitution

With bacteriostatic water, the solution should turn crystal clear and colorless, with no visible particles.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

  • Renal effects were observed in primate studies, a key safety signal in the preclinical literature.
  • No established human safety profile — among the most experimental entries in this database.

References & further reading

Adipotide (prohibitin-targeting peptide) in primates (Science Translational Medicine, 2011)

Primateadipose vasculatureweight loss

Study reporting rapid weight reduction via targeted ablation of adipose blood supply, with observed renal effects.

View study

Topics

adiposeapoptosisexperimental

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level
Emerging Research

Active but early-stage research; evidence still developing.

Quick reference
Dose rangeInvestigational (preclinical models)
RouteSubcutaneous (research)
DurationShort experimental courses
Storage2–8 °C reconstituted
Half-lifeShort (~hours)
Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue